Herencia-Ropero, A., Arribas, J., & Serra, V. (2024). The PARP1 selective inhibitor saruparib (AZD5305) elicits potent and durable antitumor activity in patient-derived BRCA1/2-associated cancer models.
Citação norma ChicagoHerencia-Ropero, Andrea, Joaquín Arribas, e Violeta Serra. The PARP1 Selective Inhibitor Saruparib (AZD5305) Elicits Potent and Durable Antitumor Activity in Patient-derived BRCA1/2-associated Cancer Models. 2024.
Citação norma MLAHerencia-Ropero, Andrea, Joaquín Arribas, e Violeta Serra. The PARP1 Selective Inhibitor Saruparib (AZD5305) Elicits Potent and Durable Antitumor Activity in Patient-derived BRCA1/2-associated Cancer Models. 2024.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.